Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

Treatment with rituximab plus a regimen of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) for patients with diffuse large B-cell lymphoma (DLBCL) has proven efficacy in clinical trials. The present study investigated its application in clinical practice. This single-center, retro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Horvat, Matej, Zadnik, Vesna, Južnič Šetina, Tanja, Boltežar, Lučka, Pahole Goličnik, Jana, Novaković, Srdjan, Jezeršek Novaković, Barbara
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2018
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796369/
https://ncbi.nlm.nih.gov/pubmed/29467881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.7774
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky